Apimeds Pharmaceuticals US, Inc. (APUS)
NYSEAMERICAN: APUS · Real-Time Price · USD
1.906
+0.046 (2.47%)
Sep 5, 2025, 4:00 PM - Market closed
APUS Employees
Apimeds Pharmaceuticals US had 2 employees as of December 31, 2024.
Employees
2
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,854,372
Market Cap
23.97M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
APUS News
- 12 days ago - Apimeds Pharmaceuticals US, Inc. Partners with University of Alabama to Advance Biotech Business Development via ai² Future Labs - Business Wire
- 7 weeks ago - Apimeds Expands Leadership Team with Dr. Susan Kramer to Lead Product Development and Brian Peters to Lead its ai² Division - Business Wire
- 4 months ago - Apimeds Pharmaceuticals US, Inc. Announces Closing of Initial Public Offering - GlobeNewsWire
- 4 months ago - U.S. IPO Weekly Recap: Sizable Insurance IPOs Deliver Solid Trading - Seeking Alpha
- 4 months ago - Apimeds Pharmaceuticals US, Inc. Announces Pricing of Initial Public Offering - GlobeNewsWire
- 1 year ago - Inflammation-focused biotech Apimeds Pharmaceuticals US files for a $12 million IPO - Renaissance Capital
- 1 year ago - Apimeds Pharmaceuticals US IPO Registration Document (S-1) - SEC